Gregory MacMichael

Gregory MacMichael

Geen lopende functies
70 jaar
Health Technology
Consumer Services

Profiel

Gregory MacMichael is the founder of CMC BioServices LLC, which was founded in 2010.
He held former positions as Vice President at Wyeth LLC, Global Head-Biologics Development at Novartis AG, Senior Vice President-Process Development at Rocket Pharmaceuticals, Inc., Senior Vice President-Development & Manufacturing at NantKwest, Inc. from 2017 to 2018, and Senior Vice President-Technical Operations at Sio Gene Therapies, Inc. from 2018 to 2019.
He was also the Chief Technology Officer at Castle Creek Biosciences, Inc. from 2020 to 2021 and Chief Technical Officer at Coya Therapeutics, Inc. He received a doctorate from Mississippi State University, a graduate and doctorate degree from North Carolina State University, and an undergraduate degree from The Pennsylvania State University.

Eerdere bekende functies van Gregory MacMichael

BedrijvenFunctieEinde
SIO GENE THERAPIES INC. Corporate Officer/Principal 01-07-2019
IMMUNITYBIO, INC. Corporate Officer/Principal 01-09-2018
ROCKET PHARMACEUTICALS, INC. Corporate Officer/Principal 01-12-2016
COYA THERAPEUTICS, INC. Hoofd Techniek/Wetenschap/O&O -
Corporate Officer/Principal -
Ervaring van Gregory MacMichael in detail bekijken

Opleiding van Gregory MacMichael

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

7

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

CMC BioServices LLC

  1. Beurs
  2. Insiders
  3. Gregory MacMichael
-40 %: de beste tools exclusief voor abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU